EVALUATION OF DAUNORUBICIN (NSC-82151) AND METHOTREXATE (NSC-740) IN COMBINATION AS A REMISSION MAINTENANCE REGIMEN IN TREATMENT OF ACUTE-LEUKEMIA

被引：0
|
作者：
HUMPHREY, GB
FERNBACH, DJ
RAZEK, AA
STUCKEY, WJ
KOMP, D
GEORGE, S
机构：
来源：
CANCER CHEMOTHERAPY REPORTS PART 1 | 1975年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：395 / 399
页数：5
相关论文
共 50 条
  • [41] INTRAVENOUS AND ORAL DEMETHOXYDAUNORUBICIN (NSC 256-439) IN THE TREATMENT OF ACUTE-LEUKEMIA AND LYMPHOMA - A PILOT-STUDY
    ERIDANI, S
    SLATER, NGP
    SINGH, AK
    PEARSON, TC
    BLUT, 1985, 50 (06): : 369 - 372
  • [42] HIGH-DOSE VP 16-213 (NSC 141540) FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY TREATED ACUTE-LEUKEMIA
    VANECHO, DA
    WIERNIK, PH
    AISNER, J
    CANCER CLINICAL TRIALS, 1980, 3 (04) : 325 - 328
  • [43] DIBROMODULCITOL (NSC-104800) COMPARED WITH CYCLOPHOSPHAMIDE (NSC-26271) AS REMISSION MAINTENANCE THERAPY IN PREVIOUSLY TREATED CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE UNDIFFERENTIATED LEUKEMIA - POSSIBLE EFFECTIVENESS IN REDUCING INCIDENCE OF CENTRAL NERVOUS-SYSTEM LEUKEMIAS
    SITARZ, AL
    ALBO, V
    MOVASSAGHI, N
    KARON, M
    HAMMOND, D
    WEINER, J
    REED, A
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (05): : 989 - 994
  • [44] TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA WITH A DAUNORUBICIN-CYTARABINE-6 THIOGUANINE REGIMEN WITHOUT MAINTENANCE THERAPY
    FREUND, M
    POLIWODA, H
    BODENSTEIN, H
    EISERT, R
    ONKOLOGIE, 1985, 8 (03): : 150 - 152
  • [45] ETOPOSIDE, 6-THIOGUANINE AND IDARUBICIN, AN ORAL COMBINATION REGIMEN (ETI) FOR THE INDUCTION TREATMENT OF ACUTE-LEUKEMIA
    RUUTU, T
    ELONEN, E
    HEMATOLOGICAL ONCOLOGY, 1991, 9 (02) : 87 - 92
  • [46] CLINICAL-EVALUATION OF COMBINATION OF CEFMETAZOLE AND PIPERACILLIN IN THE TREATMENT OF INFECTIONS IN PATIENTS WITH ACUTE-LEUKEMIA
    NAGAO, T
    KOMATSUDA, M
    YAMAUCHI, K
    NOZAKI, H
    CHEMOTHERAPY, 1983, 29 (03) : 230 - 235
  • [47] RESULTS OF TREATMENT WITH AN INTENSIVE COMBINATION INDUCTION REGIMEN CONTAINING IDARUBICIN IN CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA - PRELIMINARY-REPORT OF THE ARGENTINE GROUP FOR TREATMENT OF ACUTE-LEUKEMIA
    SACKMANNMURIEL, F
    FERNANDEZBARBIERI, MA
    SANTARELLI, MT
    MATUSRIDLEY, M
    ROSSO, A
    NEGRIARANGUREN, P
    CERUTTI, I
    GOMEL, M
    KVICALA, R
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 34 - 38
  • [48] THE TREATMENT OF ACUTE-LEUKEMIA WITH HIGH-DOSE COMBINATION CHEMOTHERAPY AND AUTO-BMT AS INTENSIFICATION IN 1ST REMISSION
    DICKE, KA
    DIXON, DO
    MCCREDIE, KB
    JAGANNATH, S
    HORWITZ, LJ
    SMITH, KE
    WALTERS, RS
    SPITZER, G
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 441 - 441
  • [49] CLINICAL AND CELL KINETIC DATA ON COMBINATION OF CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN, IFOSFAMIDE, THIOGUANINE, AND VINCRISTINE FOR REMISSION INDUCTION AND MAINTENANCE IN PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA
    BUCHNER, T
    KAMANABROO, D
    URBANITZ, D
    HIDDEMANN, W
    VANDELOO, J
    BLUT, 1978, 36 (06): : 371 - 376
  • [50] INTERMEDIATE AND HIGH-DOSE ARA-C AND M-AMSA (OR DAUNORUBICIN) AS REMISSION AND CONSOLIDATION TREATMENT FOR PATIENTS WITH RELAPSED ACUTE-LEUKEMIA AND LYMPHOBLASTIC NON-HODGKIN LYMPHOMA
    WILLEMZE, R
    PETERS, WG
    VANHENNIK, MB
    FIBBE, WE
    KOOTTE, AMM
    VANBERKEL, M
    LIE, R
    RODENBURG, CJ
    VELTKAMP, JJ
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1985, 34 (01): : 83 - 87
12345